What Researchers Did
Researchers followed 45 people with advanced cancer of the voice box (larynx) who were treated with a short, high-dose radiation schedule given while breathing oxygen at 4 atmospheres of pressure, and they tracked tumour control, survival and complications over the long term.
What They Found
In this cohort study of 45 patients with locally advanced laryngeal cancer treated with two 11 Gy radiation doses given 21 days apart, each with hyperbaric oxygen at 4 atmospheres under general anesthesia, 87% had a complete clinical response and the 10-year local control rate was 58%. Local control was 69% among the 39 complete responders. The 10-year survival of the whole group was 27%, and the 10-year voice preservation rate among complete responders was 55%. Significant late complications occurred in 14 patients, including severe fibrosis, necrosis and pharyngeal fistula, and 3 patients needed laryngectomy for complications. The actuarial rate of severe complications at 5 years was 42%.
What This Means for Canadian Patients
For laryngeal cancer, this study reports tumour control rates the authors describe as comparable to longer radiation schedules, with or without chemotherapy. The authors also describe the complication rate as high, resulting in an adverse therapeutic ratio, meaning the harms were large compared with the benefit. Patients considering any treatment that combines radiation with hyperbaric oxygen should talk with their cancer care team about these risks.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This was a single group of 45 patients treated between 1970 and 1982 with no comparison group, so the study cannot show that hyperbaric oxygen caused the results, and the unusual radiation schedule and use of general anesthesia limit how far the findings apply to other patients.